Skip to main content
Verisante Technology, Inc. logo

Verisante Technology, Inc. — Investor Relations & Filings

Ticker · VER.H ISIN · CA92346G2036 TSXV Administrative and support service activities
Filings indexed 199 across all filing types
Latest filing 2022-05-30 Regulatory Filings
Country CA Canada
Listing TSXV VER.H

About Verisante Technology, Inc.

https://www.verisante.com/

Verisante Technology, Inc. is currently structured as a non-operating public entity actively seeking a merger or acquisition candidate to complete a Reverse Takeover (RTO). The company's primary focus is identifying businesses that offer innovative solutions for commercialization. Historically, Verisante operated as a medical device company dedicated to developing and commercializing systems for the early detection of cancer. Its previous core product development included the Verisante Aura™ system, designed for non-invasive skin cancer diagnostics.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2022-05-30 English
Interim MD&A - English.pdf
Regulatory Filings
2022-05-30 English
Interim financial statements/report – English.pdf
Regulatory Filings
2022-05-30 English
Material change report - English.pdf
Regulatory Filings
2022-05-30 English
Notice of the meeting and record date - English.pdf
Regulatory Filings
2022-05-12 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed by Verisante Technology Inc. It details a material change event, specifically the revocation of a Failure to File Cease Trade Order by securities commissions. The document includes a news release about this regulatory event and provides contact information and forward-looking statements. The document length is 3096 characters, which is relatively short and primarily serves as a regulatory announcement of a material change rather than a full financial report or detailed analysis. It does not contain financial statements, earnings data, or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and compliance documents that do not fit other specific categories.
2022-04-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.